Concomitant medications during immune checkpoint blockage in cancer patients: Novel insights in this emerging clinical scenario
Giovanni Rossi(Ospedale Policlinico San Martino), Alessandro Russo(Humanitas University), Fabrizio Citarella(Università Campus Bio-Medico), Alessandro Tuzi(Ospedale di Circolo e Fondazione Macchi), Aldo Pezzuto(Unknown), Olga Nigro(Fondazione IRCCS Istituto Nazionale dei Tumori), Claudio Sini(ATS Sardegna (Italy)), Michael G. McCusker(University of Maryland, Baltimore), Enrica T. Tanda(Ospedale Policlinico San Martino)
Cited by 66
Related Papers
RET fusions in solid tumors
|Cancer Treatment Reviews|2019|256
The treatment of advanced melanoma: Current approaches and new challenges
|Critical Reviews in Oncology/Hematology|2024|140
Co-morbid anxiety disorders in bipolar disorder and major depression: familial aggregation and clinical characteristics of co-morbid panic disorder, social phobia, specific phobia and obsessive-compulsive disorder
|Psychological Medicine|2011|137
Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)
|Critical Reviews in Oncology/Hematology|2020|135